Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

In this webinar you’ll learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology ‒ from monitoring the cardiotoxic effects of chemotherapy treatment to developing blood-based protein-only tests for stratifying lung cancer susceptibility.

Watch this webinar to discover how:

• Proteomic risk scores can be used to identify high risk patients and monitor for adverse effects
• To analyze thousands of proteins to develop cancer susceptibility models
  High-throughput proteomics can inform and impact patients' standard of care